Kevin C Barry
6PUBLICATIONS
25CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Oct 13, 2025
IL2/IL15 Signaling Induces NK Cell Production of FLT3LG, Augmenting Anti-PD-1 Immunotherapy.Shayan C Avanessian, Renske J E van den Bijgaart, Nayvin W Chew
|Feb 19, 2022
Holistic Characterization of Tumor Monocyte-to-Macrophage Differentiation Integrates Distinct Immune Phenotypes in Kidney Cancer.Adriana M Mujal, Alexis J Combes, Arjun A Rao
|Sep 14, 2021
FLT3L Release by Natural Killer Cells Enhances Response to Radioimmunotherapy in Preclinical Models of HNSCC.Thomas E Bickett, Michael Knitz, Laurel B Darragh
|Jul 22, 2020
The NK cell-cancer cycle: advances and new challenges in NK cell-based immunotherapies.Tobias Bald, Matthew F Krummel, Mark J Smyth
|Jun 27, 2018
A natural killer-dendritic cell axis defines checkpoint therapy-responsive tumor microenvironments.Kevin C Barry, Joy Hsu, Miranda L Broz
|Apr 07, 2017
Global analysis of gene expression reveals mRNA superinduction is required for the inducible immune response to a bacterial pathogen.Kevin C Barry, Nicholas T Ingolia, Russell E Vance
Pageof 1
Frequent Collaborators
2 joint publications
Matthew F Krummel
1 joint publications
Thomas E Bickett
1 joint publications
Michael Knitz
1 joint publications
Miles Piper
1 joint publications
Diemmy Nguyen
1 joint publications
Laurel Lenz
1 joint publications
Eric T Clambey
1 joint publications
Nicholas T Ingolia
1 joint publications
Russell E Vance
1 joint publications
Adil I Daud
